Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This clinical study is designed to test the hypothesis that lurasidone is effective,
tolerable, and safe for the treatment of patients with bipolar I depression